NCT06377527View on ClinicalTrials.gov

Establishing a Tumor Registry of Patients With Mesonephric-like Adenocarcinoma (MLA)

RecruitingOBSERVATIONAL

Enrollment

2,000

Participants

Timeline

Start Date

July 10, 2024

Primary Completion Date

December 28, 2035

Study Completion Date

December 28, 2037

Conditions

Mesonephric-like Adenocarcinoma

Trial Locations (1)

77030

RECRUITING

MD Anderson Cancer Center, Houston

All Listed Sponsors

lead

M.D. Anderson Cancer Center

OTHER